Drug Guide

Generic Name

Benzhydrocodone Hydrochloride with Acetaminophen

Brand Names Apadaz

Classification

Therapeutic: Analgesic, opioid analgesic combination

Pharmacological: Narcotic analgesic, opioid receptor agonist and non-opioid analgesic (acetaminophen)

FDA Approved Indications

Mechanism of Action

Benzhydrocodone binds to and activates opioid receptors in the central nervous system, altering the perception of and response to pain. Acetaminophen inhibits prostaglandin synthesis in the CNS, providing analgesic and antipyretic effects.

Dosage and Administration

Adult: Typically, 1-2 tablets every 4-6 hours as needed, not to exceed 12 tablets per day.

Pediatric: Not recommended for use in children under 18 years of age.

Geriatric: Adjust dosage carefully, usually starting at the lower end of dosing range due to increased risk of adverse effects.

Renal Impairment: Use with caution; dosage adjustments may be necessary.

Hepatic Impairment: Use with caution; dose adjustments recommended, particularly due to acetaminophen's hepatotoxicity risk.

Pharmacokinetics

Absorption: Rapidly absorbed from the gastrointestinal tract.

Distribution: Widely distributed throughout the body, crosses the blood-brain barrier.

Metabolism: Metabolized in the liver via conjugation pathways.

Excretion: Primarily excreted in urine.

Half Life: Approximately 3.5 hours for benzhydrocodone; 2-3 hours for acetaminophen.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

Drug-Herb Interactions

Nursing Implications

Assessment: Monitor pain relief, respiratory status, liver function tests, and signs of misuse or abuse.

Diagnoses:

  • Ineffective airway clearance related to respiratory depression.
  • Risk for injury related to sedation or dizziness.
  • Impaired liver function.

Implementation: Administer with food to reduce gastrointestinal irritation. Monitor for signs of adverse effects. Educate patient on proper dosing.

Evaluation: Assess pain relief effectiveness. Monitor for adverse reactions, especially respiratory depression and hepatotoxicity.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: Genetic variations in CYP2D6 enzyme activity may affect drug metabolism.

Lab Test Interference: May interfere with certain liver function tests or urine drug screens.

Overdose Management

Signs/Symptoms: Respiratory depression, extreme drowsiness, cold and clammy skin, pinpoint pupils, coma.

Treatment: Administer naloxone for opioid overdose, provide supportive respiratory and cardiovascular care, and monitor patient closely.

Storage and Handling

Storage: Store at room temperature, away from moisture, light, and children.

Stability: Stable under recommended storage conditions for the duration of the shelf life.

This guide is for educational purposes only and is not intended for clinical use.